Molecular Mechanisms of Fit but Fat: Coronary Function and Muscle Mass

健康但肥胖的分子机制:冠状动脉功能和肌肉质量

基本信息

  • 批准号:
    7991000
  • 负责人:
  • 金额:
    $ 18.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-15 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Obesity is a major health threat in Western medicine primarily due to its effects on cardiovascular function. As this epidemic unfolds, new therapies and interventions are needed and clues can be found in the fact that exercise is a major positive factor in cardiovascular outcome in all disease states, including obesity. Since obese individuals often have difficult exercising at an effective level to achieve cardiovascular benefit, it would be useful to re-create in this population the effects of exercise using alternative approaches. A major benefit of exercise in the size and quality of muscle mass, which may improve metabolic or hemodynamic function in ways that contribute to cardiovascular benefit. In this application, we present a novel model of obesity in which we have increased muscle mass by genetic deletion of myostatin, a growth factor which restrains muscle mass under normal conditions. The result is an obese mouse that has increase muscularity, improvements in metabolic status and initial evidence of improved cardiovascular performance. We will use this animal to test the broad hypothesis of the application, that increases in muscle mass ameliorate the cardiovascular deficits of obesity in two specific aims. Aim 1 will examine vascular function, specifically in the form of endothelial dilation to determine if improvement in muscle mass restores endothelium-dependent dilation. Aim 2 will determine is increases in muscle mass prevent the increase in oxidants induced by obesity which are thought to account for many of the cardiovascular deficits in obese individuals. Aim 3 will examine cardiac function by determining is muscle mass reduces the progression of contractile dysfunction and reduces risk of ischemia in obesity. Taken together these data will provide new information about the relationship between muscle mass and cardiometabolic status in obesity and may identify a novel therapeutic venue in this emerging epidemic. PUBLIC HEALTH RELEVANCE: Obesity is one of the leading cause of cardiovascular diseases, but the therapies are few. Exercise provides good protection from cardiovascular disease but mechanisms are unclear and obese individual cannot exercise enough to get benefit. This application will focus on a new intervention, increasing muscle mass with deletion of myostatin in obesity and determine the extent to which this manipulation improves cardiovascular function and confers the benefits of exercise on obese individuals.
描述(申请人提供):肥胖是西医的一个主要健康威胁,主要是由于它对心血管功能的影响。随着这种流行病的蔓延,需要新的治疗方法和干预措施,而且可以从以下事实中找到线索:运动是包括肥胖在内的所有疾病状态下心血管结果的主要积极因素。由于肥胖者通常很难在有效的水平上进行锻炼以获得心血管益处,因此在这一人群中使用替代方法重新创造锻炼的效果将是有用的。锻炼对肌肉的大小和质量有很大的好处,可以改善代谢或血流动力学功能,从而对心血管有益。在这个应用中,我们提出了一种新的肥胖模型,在该模型中,我们通过基因缺失Myostatin来增加肌肉质量,Myostatin是一种在正常情况下抑制肌肉质量的生长因子。结果是肥胖的小鼠肌肉发达,代谢状态得到改善,心血管功能得到改善的初步证据。我们将使用这只动物来测试这一应用的广泛假设,即增加肌肉质量在两个特定目标上改善肥胖的心血管缺陷。目标1将检查血管功能,特别是内皮扩张的形式,以确定肌肉质量的改善是否恢复内皮依赖性扩张。目标2将确定肌肉质量的增加是否可以防止肥胖引起的氧化剂的增加,后者被认为是肥胖者许多心血管缺陷的原因。目标3将通过确定肌肉质量是否可以减少肥胖症患者收缩功能障碍的进展并降低缺血风险来检查心脏功能。综上所述,这些数据将提供有关肥胖症患者肌肉质量和心脏代谢状态之间关系的新信息,并可能确定这一新流行病的治疗地点。 公共卫生相关性:肥胖是心血管疾病的主要原因之一,但治疗方法很少。运动可以很好地预防心血管疾病,但机制尚不清楚,肥胖者无法进行足够的运动来获得好处。这项应用将专注于一种新的干预措施,通过删除肥胖患者的肌肉抑制素来增加肌肉质量,并确定这种操作在多大程度上改善心血管功能,并赋予肥胖者运动的好处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David W Stepp其他文献

David W Stepp的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David W Stepp', 18)}}的其他基金

Multi-Disciplinary Training Program in the Mechanisms of Cardiometabolic Disease
心脏代谢疾病机制多学科培训项目
  • 批准号:
    10270576
  • 财政年份:
    2021
  • 资助金额:
    $ 18.63万
  • 项目类别:
Multi-Disciplinary Training Program in the Mechanisms of Cardiometabolic Disease
心脏代谢疾病机制多学科培训项目
  • 批准号:
    10633091
  • 财政年份:
    2021
  • 资助金额:
    $ 18.63万
  • 项目类别:
Multi-Disciplinary Training Program in the Mechanisms of Cardiometabolic Disease
心脏代谢疾病机制多学科培训项目
  • 批准号:
    10375595
  • 财政年份:
    2021
  • 资助金额:
    $ 18.63万
  • 项目类别:
Molecular Mechanisms of Fit but Fat: Coronary Function and Muscle Mass
健康但肥胖的分子机制:冠状动脉功能和肌肉质量
  • 批准号:
    8110078
  • 财政年份:
    2010
  • 资助金额:
    $ 18.63万
  • 项目类别:
Mechanisms of Peripheral Microvascular Disease
周围微血管疾病的机制
  • 批准号:
    6872681
  • 财政年份:
    2005
  • 资助金额:
    $ 18.63万
  • 项目类别:
Mechanisms of Peripheral Microvascular Disease
周围微血管疾病的机制
  • 批准号:
    7008881
  • 财政年份:
    2005
  • 资助金额:
    $ 18.63万
  • 项目类别:
Mechanisms of Peripheral Microvascular Disease
周围微血管疾病的机制
  • 批准号:
    7337066
  • 财政年份:
    2005
  • 资助金额:
    $ 18.63万
  • 项目类别:
Mechanisms of Peripheral Microvascular Disease
周围微血管疾病的机制
  • 批准号:
    7162629
  • 财政年份:
    2005
  • 资助金额:
    $ 18.63万
  • 项目类别:
Nitric Oxide and Compensatory Coronary Vasodilation
一氧化氮和代偿性冠状动脉舒张
  • 批准号:
    6650329
  • 财政年份:
    2001
  • 资助金额:
    $ 18.63万
  • 项目类别:
Nitric Oxide and Compensatory Coronary Vasodilation
一氧化氮和代偿性冠状动脉舒张
  • 批准号:
    6500065
  • 财政年份:
    2001
  • 资助金额:
    $ 18.63万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKT cell activation depend on lipid accumulation in adipocytes
NKT 细胞的激活取决于脂肪细胞中的脂质积累
  • 批准号:
    22K08679
  • 财政年份:
    2022
  • 资助金额:
    $ 18.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了